Skip to main navigation Skip to search Skip to main content

Neurochemical abnormalities of anorexia nervosa and bulimia nervosa

M. Fava, P. M. Copeland, U. Schweiger, D. B. Herzog

Abstract

The authors review the research on anorexia nervosa and bulimia nervosa, emphasizing the neurotransmitters and neuromodulators that regulate eating behavior. Anorexia nervosa is associated with changes in the noradrenergic, serotonergic, and opioid systems; bulimia is accompanied by marked alterations in serotonin and norepinephrine activity. These neurochemical changes may perpetuate pathologic eating behavior and may be responsible for several associated psychiatric symptoms, including anxiety and depression. The authors also summarize studies of several drugs that are used in the treatment of eating disorders and are known to modify neurotransmitter activity. Understanding the neurochemistry of eating disorders seems crucial for the rational development of both psychopharmacological and behavioral treatments.

Original languageEnglish
JournalAmerican Journal of Psychiatry
Volume146
Issue number8
Pages (from-to)963-971
Number of pages9
ISSN0002-953X
DOIs
Publication statusPublished - 1989

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  2. SDG 10 - Reduced Inequalities
    SDG 10 Reduced Inequalities

Research Areas and Centers

  • Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)

Fingerprint

Dive into the research topics of 'Neurochemical abnormalities of anorexia nervosa and bulimia nervosa'. Together they form a unique fingerprint.

Cite this